Aug 6, 2026 04:01PM
Jun 3, 2026 09:02AM
May 11, 2026 04:01PM
Apr 30, 2026 08:00AM
Apr 30, 2026 08:00AM
Apr 7, 2026 11:08AM
Feb 19, 2026 10:25AM Halozyme Therapeutics (HALO) PT Raised to $90 at Benchmark Following Strong Q4 Results
Feb 17, 2026 04:01PM
Jan 28, 2026 06:30AM
Jan 8, 2026 09:30AM
Dec 8, 2025 04:05PM
Dec 8, 2025 04:05PM
Dec 4, 2025 06:51AM
Nov 28, 2025 06:34AM H.C. Wainwright Reiterates Buy Rating on Halozyme Therapeutics (HALO)
Nov 18, 2025 08:50AM
Nov 18, 2025 08:50AM
Nov 3, 2025 04:01PM
Oct 2, 2025 04:28AM
Oct 1, 2025 07:01AM
Oct 1, 2025 07:00AM
Feb 18, 2025 04:01PM HALOZYME REPORTS FULL YEAR 2024 RECORD REVENUE OF $1.015 BILLION AND EXCEEDS ITS FINANCIAL GUIDANCE FOR ROYALTY REVENUE, ADJUSTED EBITDA AND NON-GAAP DILUTED EPS
Nov 25, 2024 06:43AM
Nov 22, 2024 11:22AM
Nov 22, 2024 09:17AM
Nov 22, 2024 08:35AM
Nov 22, 2024 08:35AM
Nov 18, 2024 07:03AM
Nov 18, 2024 07:00AM Halozyme Provides Update on Non-Binding Proposal to Combine with Evotec
Nov 15, 2024 07:40AM
Nov 14, 2024 04:26PM
Nov 14, 2024 04:16PM
Nov 14, 2024 04:15PM
Oct 31, 2024 04:01PM
Aug 6, 2024 04:01PM
May 7, 2024 04:01PM HALOZYME REPORTS FIRST QUARTER 2024 FINANCIAL AND OPERATING RESULTS
Feb 20, 2024 04:01PM
Nov 6, 2023 04:01PM
Aug 8, 2023 04:01PM
May 9, 2023 04:01PM
Feb 21, 2023 04:01PM
Jan 10, 2023 05:15PM
Nov 8, 2022 04:01PM HALOZYME REPORTS THIRD QUARTER 2022 FINANCIAL AND OPERATING RESULTS
Sep 22, 2022 05:00PM
Aug 10, 2022 09:03AM
Aug 9, 2022 04:01PM
Jul 1, 2022 04:15PM
Jun 16, 2022 06:37PM
May 24, 2022 08:30AM
May 23, 2022 03:41AM UPDATE: SVB Leerink Assumes Halozyme Therapeutics (HALO) at Outperform, 'Durability Underappreciated for This Partner of Choice'
May 21, 2022 03:16AM

1,177,135 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All